Explores the development of new pharmaceutical excipients using copovidone and silicon dioxide, suggesting improved solubilization and binding properties.
Vinylpyrrolidone-vinyl acetate copolymer (copovidone) is commonly used in oral solid dosage systems for its solubilizing and binding properties but suffers from native hygroscopicity and high mechanical fiber strength of its...
No takes yet. Share an insight, caveat, or question.
Vishwakarma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: